Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

360
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

313
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

645
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
645
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

423
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
423
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

692
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
692
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

308
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
308

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observations Regarding Evaluation of an After-Hours Call Center: Are Pediatric Patients Appropriately Referred to the Emergency Department?

Pediatric emergency care·2015
Same author

Telephone triage liability: protecting your patients and your practice from harm.

Advances in pediatrics·2008
Same author

Concerns over alternating acetaminophen and ibuprofen for fever.

Archives of pediatrics & adolescent medicine·2006
Same author

An assessment of pediatric after-hours telephone care: a 1-year experience.

Archives of pediatrics & adolescent medicine·2005
Same author

Group A beta-hemolytic streptococcal vulvovaginitis: diagnosis by rapid antigen testing.

Clinical pediatrics·2004
Same author

Preventing unnecessary emergency department visits for "albuterol nebs".

Archives of pediatrics & adolescent medicine·2002

Related Experiment Video

Updated: Mar 17, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

15.6K

Pediatrics.

Barton D Schmitt1

  • 1a University of Colorado Medical Center Denver.

Postgraduate Medicine
|July 21, 2016
PubMed
Summary
This summary is machine-generated.

Cervical adenopathies present in various forms, including acute, subacute, unilateral, bilateral, pyogenic, and nonpyogenic. Penicillin effectively treats nonstaphylococcal pyogenic adenitis.

More Related Videos

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.8K
How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

12.8K

Related Experiment Videos

Last Updated: Mar 17, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

15.6K
Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.8K
How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

12.8K

Area of Science:

  • Medicine
  • Infectious Diseases
  • Oncology

Background:

  • Cervical adenopathies encompass a wide spectrum of conditions, varying in onset, laterality, etiology, and nature.
  • These conditions can range from acute to subacute presentations and from benign to malignant processes.

Purpose of the Study:

  • To outline the diverse clinical presentations of cervical adenopathies.
  • To identify the primary therapeutic agent for nonstaphylococcal pyogenic adenitis.

Main Methods:

  • Literature review of cervical adenopathies.
  • Clinical guidelines for infectious adenitis.

Main Results:

  • Cervical adenopathies are classified based on clinical and etiological factors.
  • Penicillin is established as the first-line treatment for nonstaphylococcal pyogenic adenitis.

Conclusions:

  • Understanding the varied nature of cervical adenopathies is crucial for diagnosis.
  • Penicillin remains the drug of choice for specific types of bacterial cervical adenitis.